← FDA Drug Approvals (Drugs@FDA)

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2024-05-16

Drug application

FDA Application #

ANDA214987

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Generic name

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Active ingredients

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

GLENMARK PHARMS LTD

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2024-05-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown